| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
37,026 |
35,543 |
$6.02M |
| G0378 |
Hospital observation service, per hour |
8,389 |
3,183 |
$2.26M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
19,757 |
18,790 |
$2.03M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
11,559 |
11,092 |
$2.00M |
| T1015 |
Clinic visit/encounter, all-inclusive |
14,401 |
12,983 |
$398K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
18,156 |
17,290 |
$327K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,391 |
2,338 |
$279K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,307 |
4,144 |
$204K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
209 |
195 |
$180K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,783 |
3,406 |
$165K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
41,293 |
34,704 |
$140K |
| 80053 |
Comprehensive metabolic panel |
17,891 |
16,422 |
$130K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
18,287 |
17,113 |
$117K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
20,007 |
16,172 |
$96K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,955 |
7,057 |
$89K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,586 |
1,558 |
$83K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
319 |
312 |
$81K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,421 |
1,387 |
$70K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,204 |
1,142 |
$69K |
| 71045 |
Radiologic examination, chest; single view |
13,108 |
12,485 |
$66K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
506 |
494 |
$65K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
331 |
324 |
$64K |
| 73221 |
|
261 |
253 |
$59K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
348 |
342 |
$57K |
| 84484 |
|
9,082 |
8,280 |
$55K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
383 |
373 |
$49K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
140 |
139 |
$49K |
| J0475 |
Injection, baclofen, 10 mg |
538 |
522 |
$46K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
742 |
735 |
$38K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
597 |
569 |
$36K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
466 |
290 |
$34K |
| 73610 |
|
2,329 |
2,144 |
$34K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
600 |
573 |
$34K |
| 73630 |
|
3,819 |
3,519 |
$34K |
| 72141 |
|
187 |
184 |
$34K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
271 |
270 |
$33K |
| J3490 |
Unclassified drugs |
13,629 |
7,994 |
$32K |
| 70498 |
|
239 |
235 |
$30K |
| 83735 |
|
9,229 |
6,309 |
$29K |
| 16020 |
|
1,423 |
1,030 |
$28K |
| 70496 |
|
215 |
213 |
$28K |
| 70486 |
|
509 |
498 |
$27K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
576 |
562 |
$26K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
213 |
208 |
$26K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
119 |
117 |
$22K |
| Q3014 |
Telehealth originating site facility fee |
1,397 |
1,313 |
$22K |
| 80050 |
General health panel |
574 |
551 |
$20K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
670 |
621 |
$20K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
336 |
325 |
$19K |
| 73030 |
|
1,448 |
1,372 |
$18K |
| 84100 |
|
6,802 |
4,482 |
$18K |
| 76801 |
|
435 |
422 |
$17K |
| 93975 |
|
192 |
187 |
$17K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
54 |
50 |
$16K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,160 |
1,652 |
$16K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
978 |
948 |
$15K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
525 |
515 |
$15K |
| 83690 |
|
4,835 |
4,538 |
$15K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
459 |
305 |
$15K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
982 |
952 |
$15K |
| 93971 |
|
296 |
276 |
$14K |
| 71250 |
|
317 |
301 |
$14K |
| 84443 |
Thyroid stimulating hormone (TSH) |
988 |
947 |
$14K |
| 73564 |
|
793 |
762 |
$13K |
| 80061 |
Lipid panel |
1,396 |
1,342 |
$13K |
| 84703 |
|
1,824 |
1,800 |
$12K |
| 81025 |
|
4,751 |
4,560 |
$12K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
133 |
132 |
$12K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
10,099 |
9,463 |
$12K |
| 71046 |
Radiologic examination, chest; 2 views |
1,040 |
997 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
588 |
537 |
$11K |
| J1815 |
Injection, insulin, per 5 units |
1,442 |
759 |
$11K |
| 90715 |
|
1,690 |
1,635 |
$10K |
| 85730 |
|
2,668 |
2,564 |
$10K |
| 96367 |
|
525 |
350 |
$10K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
571 |
551 |
$10K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
470 |
446 |
$10K |
| 85610 |
|
4,676 |
4,126 |
$10K |
| 74183 |
|
24 |
24 |
$10K |
| 80076 |
|
1,793 |
1,642 |
$9K |
| 82803 |
|
401 |
380 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,995 |
1,929 |
$8K |
| 72100 |
|
437 |
432 |
$8K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
26,044 |
12,534 |
$8K |
| 83605 |
|
1,633 |
1,456 |
$8K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
51 |
51 |
$8K |
| 76830 |
Ultrasound, transvaginal |
193 |
191 |
$8K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
837 |
803 |
$8K |
| J2785 |
Injection, regadenoson, 0.1 mg |
153 |
146 |
$7K |
| 81003 |
|
3,585 |
3,414 |
$7K |
| 93017 |
|
266 |
260 |
$7K |
| 83880 |
|
383 |
362 |
$7K |
| 73502 |
|
434 |
419 |
$7K |
| 73562 |
|
472 |
457 |
$7K |
| 82962 |
|
5,332 |
3,461 |
$6K |
| 11721 |
|
759 |
740 |
$6K |
| 73590 |
|
531 |
500 |
$6K |
| 76536 |
|
156 |
152 |
$6K |
| 73700 |
|
113 |
112 |
$6K |
| 73560 |
|
392 |
367 |
$6K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
231 |
225 |
$6K |
| 87040 |
|
590 |
369 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,132 |
1,052 |
$6K |
| 76775 |
|
173 |
168 |
$6K |
| J3535 |
Drug administered through a metered dose inhaler |
1,227 |
1,157 |
$6K |
| 73130 |
|
672 |
638 |
$6K |
| 62370 |
|
262 |
250 |
$6K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
523 |
388 |
$5K |
| 81002 |
|
2,338 |
2,249 |
$5K |
| 85027 |
|
1,575 |
1,353 |
$5K |
| 80305 |
|
821 |
785 |
$5K |
| 82728 |
|
551 |
538 |
$5K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
152 |
145 |
$5K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
105 |
105 |
$5K |
| 43235 |
|
25 |
25 |
$5K |
| 80329 |
|
462 |
443 |
$4K |
| 86850 |
|
985 |
948 |
$4K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
742 |
721 |
$4K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
271 |
154 |
$4K |
| 87905 |
|
467 |
452 |
$4K |
| 43248 |
|
12 |
12 |
$4K |
| 82607 |
|
514 |
495 |
$4K |
| 85379 |
|
560 |
546 |
$4K |
| 93970 |
|
71 |
71 |
$4K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
9,657 |
5,039 |
$4K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
233 |
226 |
$4K |
| G0008 |
Administration of influenza virus vaccine |
477 |
456 |
$4K |
| 73110 |
|
445 |
425 |
$4K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
63 |
59 |
$3K |
| 64642 |
|
80 |
74 |
$3K |
| 87808 |
|
462 |
447 |
$3K |
| 82565 |
|
1,213 |
1,171 |
$3K |
| 73552 |
|
266 |
255 |
$3K |
| 84439 |
|
675 |
630 |
$3K |
| 94729 |
|
139 |
133 |
$3K |
| 86702 |
|
322 |
314 |
$3K |
| 70544 |
|
17 |
17 |
$3K |
| 84153 |
|
150 |
141 |
$3K |
| 83540 |
|
504 |
487 |
$3K |
| 81001 |
|
1,533 |
1,463 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
39 |
39 |
$3K |
| 86701 |
|
322 |
314 |
$3K |
| 82550 |
|
567 |
512 |
$3K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
377 |
285 |
$3K |
| J3473 |
Injection, hyaluronidase, recombinant, 1 usp unit |
572 |
523 |
$2K |
| J8501 |
Aprepitant, oral, 5 mg |
362 |
316 |
$2K |
| 87186 |
|
487 |
459 |
$2K |
| 87390 |
|
321 |
313 |
$2K |
| 72131 |
|
48 |
46 |
$2K |
| 82784 |
|
90 |
84 |
$2K |
| 94726 |
|
119 |
112 |
$2K |
| 86901 |
|
989 |
952 |
$2K |
| 74178 |
|
12 |
12 |
$2K |
| 86900 |
|
988 |
952 |
$2K |
| 87205 |
|
828 |
795 |
$2K |
| 74018 |
|
230 |
219 |
$2K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
712 |
614 |
$2K |
| 82043 |
|
351 |
341 |
$2K |
| 82330 |
|
404 |
380 |
$2K |
| 82746 |
|
240 |
234 |
$2K |
| 72170 |
|
290 |
287 |
$2K |
| 87077 |
|
399 |
378 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,931 |
1,783 |
$2K |
| 84702 |
|
150 |
142 |
$2K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,165 |
646 |
$2K |
| 85576 |
|
127 |
121 |
$2K |
| 85652 |
|
822 |
761 |
$2K |
| 83550 |
|
491 |
474 |
$2K |
| 86140 |
|
821 |
758 |
$2K |
| 86706 |
|
142 |
138 |
$2K |
| 82977 |
|
200 |
180 |
$2K |
| 87075 |
|
328 |
306 |
$1K |
| 72040 |
|
111 |
111 |
$1K |
| P9045 |
Infusion, albumin (human), 5%, 250 ml |
198 |
26 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
42 |
41 |
$1K |
| 73090 |
|
183 |
176 |
$1K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,630 |
2,511 |
$1K |
| 87070 |
|
426 |
401 |
$1K |
| 87340 |
|
113 |
111 |
$1K |
| 73060 |
|
167 |
163 |
$1K |
| 73080 |
|
172 |
167 |
$1K |
| 93923 |
|
26 |
26 |
$1K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
2,104 |
1,896 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
10,370 |
8,750 |
$1K |
| 87522 |
Neg quan hep c or qual rna |
31 |
31 |
$1K |
| 36430 |
|
14 |
12 |
$1K |
| 97162 |
|
311 |
297 |
$1K |
| C9399 |
Unclassified drugs or biologicals |
186 |
160 |
$1K |
| 86803 |
|
76 |
75 |
$1K |
| 86704 |
|
82 |
80 |
$958.93 |
| 86780 |
|
79 |
75 |
$948.53 |
| 88342 |
|
60 |
56 |
$944.97 |
| 94060 |
|
135 |
127 |
$881.11 |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,561 |
982 |
$870.30 |
| 84520 |
|
308 |
296 |
$869.04 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
7,334 |
5,691 |
$867.07 |
| 97161 |
|
191 |
187 |
$831.23 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,626 |
3,918 |
$824.81 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
3,201 |
1,255 |
$813.79 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
16 |
16 |
$805.40 |
| 82105 |
|
42 |
39 |
$763.91 |
| 76937 |
|
211 |
197 |
$742.52 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
162 |
153 |
$723.76 |
| 88112 |
|
41 |
37 |
$716.95 |
| 76870 |
|
25 |
25 |
$715.75 |
| 85007 |
|
322 |
290 |
$691.48 |
| 82947 |
|
375 |
348 |
$691.07 |
| 95991 |
|
107 |
91 |
$684.02 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
14,344 |
11,455 |
$650.58 |
| 70491 |
|
12 |
12 |
$639.38 |
| 84134 |
|
62 |
55 |
$619.02 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
518 |
461 |
$577.06 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
20 |
20 |
$575.43 |
| 90682 |
|
129 |
113 |
$569.38 |
| 86038 |
|
55 |
54 |
$567.15 |
| 80177 |
|
57 |
53 |
$553.94 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
20 |
12 |
$521.85 |
| 85014 |
|
343 |
322 |
$514.60 |
| 83970 |
|
16 |
14 |
$513.27 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,212 |
1,824 |
$496.39 |
| 77002 |
|
12 |
12 |
$484.07 |
| 11056 |
|
13 |
12 |
$478.07 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
132 |
131 |
$471.12 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
414 |
191 |
$456.20 |
| 0001A |
|
18 |
18 |
$452.00 |
| 76942 |
|
143 |
133 |
$432.06 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
961 |
808 |
$419.06 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
12 |
12 |
$409.11 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
560 |
334 |
$390.00 |
| 86592 |
|
124 |
119 |
$371.96 |
| 83615 |
|
88 |
73 |
$364.39 |
| 82378 |
|
47 |
40 |
$357.48 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
214 |
179 |
$356.00 |
| 29581 |
|
43 |
36 |
$329.56 |
| 72110 |
|
14 |
14 |
$328.92 |
| 73070 |
|
33 |
30 |
$325.30 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,582 |
2,199 |
$311.01 |
| 80051 |
|
95 |
92 |
$288.22 |
| 84132 |
|
109 |
100 |
$283.28 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
1,443 |
1,057 |
$276.43 |
| 73140 |
|
44 |
43 |
$272.07 |
| 99153 |
Mod sedat endo service >5yrs |
143 |
135 |
$264.02 |
| 87147 |
|
74 |
72 |
$258.83 |
| J7999 |
Compounded drug, not otherwise classified |
3,953 |
2,304 |
$257.93 |
| 90674 |
|
73 |
72 |
$250.78 |
| J2060 |
Injection, lorazepam, 2 mg |
2,107 |
1,625 |
$246.05 |
| J1630 |
Injection, haloperidol, up to 5 mg |
933 |
787 |
$242.64 |
| 85018 |
|
152 |
142 |
$235.05 |
| 84165 |
|
25 |
25 |
$233.96 |
| 96376 |
|
549 |
277 |
$224.85 |
| 93308 |
|
12 |
12 |
$212.85 |
| V2632 |
Posterior chamber intraocular lens |
65 |
61 |
$212.04 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
6,077 |
5,348 |
$207.73 |
| 74220 |
|
20 |
18 |
$207.07 |
| 87081 |
|
82 |
77 |
$192.70 |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,633 |
1,769 |
$186.06 |
| S0028 |
Injection, famotidine, 20 mg |
937 |
766 |
$183.30 |
| 36415 |
Collection of venous blood by venipuncture |
3,453 |
2,315 |
$182.98 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
423 |
192 |
$173.98 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
250 |
161 |
$169.75 |
| L1830 |
Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf |
14 |
14 |
$160.64 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
730 |
658 |
$155.26 |
| 84295 |
|
54 |
54 |
$154.71 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
160 |
135 |
$152.72 |
| 73600 |
|
25 |
24 |
$147.47 |
| 88304 |
|
184 |
181 |
$144.95 |
| 82570 |
|
29 |
27 |
$143.58 |
| J3470 |
Injection, hyaluronidase, up to 150 units |
45 |
35 |
$141.84 |
| J2704 |
Injection, propofol, 10 mg |
3,491 |
2,807 |
$140.24 |
| 86705 |
|
12 |
12 |
$137.91 |
| 87088 |
|
28 |
26 |
$126.06 |
| 94761 |
|
203 |
185 |
$113.70 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
13 |
13 |
$94.38 |
| J1953 |
Injection, levetiracetam, 10 mg |
108 |
81 |
$93.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
389 |
332 |
$88.46 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
14 |
12 |
$85.20 |
| 85049 |
|
51 |
49 |
$75.66 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
797 |
655 |
$75.24 |
| J3480 |
Injection, potassium chloride, per 2 meq |
374 |
253 |
$74.15 |
| 29540 |
|
15 |
12 |
$74.10 |
| 95874 |
|
77 |
68 |
$72.81 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
14 |
12 |
$69.96 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
57 |
44 |
$69.53 |
| J3360 |
Injection, diazepam, up to 5 mg |
15 |
12 |
$59.08 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
36 |
25 |
$47.44 |
| 64643 |
|
18 |
15 |
$44.77 |
| 82270 |
|
16 |
16 |
$42.32 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
247 |
203 |
$40.44 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,048 |
1,514 |
$38.91 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
68 |
46 |
$28.89 |
| J1940 |
Injection, furosemide, up to 20 mg |
57 |
31 |
$28.26 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
2,783 |
2,439 |
$27.63 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
93 |
83 |
$26.28 |
| 99152 |
|
15 |
15 |
$26.14 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
20 |
14 |
$24.36 |
| J3411 |
Injection, thiamine hcl, 100 mg |
20 |
12 |
$24.32 |
| 89051 |
|
17 |
13 |
$23.10 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
1,390 |
765 |
$20.51 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,050 |
622 |
$20.06 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
547 |
417 |
$14.00 |
| 94760 |
|
116 |
84 |
$13.45 |
| 64644 |
|
13 |
12 |
$13.33 |
| A4351 |
Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each |
25 |
24 |
$3.93 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
77 |
39 |
$1.18 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
120 |
117 |
$0.69 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
127 |
120 |
$0.48 |
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
35 |
29 |
$0.12 |
| 91300 |
|
12 |
12 |
$0.08 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
591 |
576 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
70 |
69 |
$0.00 |
| C1769 |
Guide wire |
56 |
54 |
$0.00 |
| 90677 |
|
12 |
12 |
$0.00 |
| Q0247 |
Injection, sotrovimab, 500 mg |
37 |
37 |
$0.00 |
| 90673 |
|
27 |
27 |
$0.00 |
| J0574 |
Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine |
37 |
12 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
13 |
12 |
$0.00 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
15 |
12 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
385 |
358 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
160 |
158 |
$0.00 |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
266 |
261 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
303 |
202 |
$0.00 |
| 90750 |
|
12 |
12 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
41 |
38 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
26 |
26 |
$0.00 |